[20] The pooled OR indicates that PD-L1 positivity was closely related to IDH1 status (OR = 9.92, P = 0.007) [20], revealing that CTLs in the GBM microenvironment are more effective in IDH1 mutant GBM. The gene discussed is IDH1; the disease is glioblastoma.